Science and practiceManagement of obstructive sleep apnoea/hypopnoea syndrome
References (34)
- et al.
Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares
Lancet
(1981) - et al.
Uvulopalatopharyngoplasty. One-year follow-up
Chest
(1985) - et al.
Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients
Chest
(1988) - et al.
Long-term survival of patients with obstructive sleep apnea treated by uvulopalatopharyngoplasty or nasal CPAP
Chest
(1994) - et al.
Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome
Lancet
(1994) - et al.
A cause of excessive daytime sleepiness. The upper airway resistance syndrome
Chest
(1993) - et al.
Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea
Chest
(1990) - et al.
Obstructive sleep apneo treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask: physiologic and clinical implications
Chest
(1990) - et al.
Treatment of snoring and obstructive sleep apnea with a dental orthosis
Chest
(1991) - et al.
Transtracheal oxygen, nasal CPAP and nasal oxygen in five patients with obstructive sleep apnea
Chest
(1992)
Effects of short-term NIPPV in the treatment of severe obstructive sleep apnea and hypercapnia
Chest
Maxillofacial surgery and nasal CPAP. A comparison of treatment for obstructive sleep apnea syndrome
Chest
Clinical value of polysomnography
Lancet
Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty
Orolaryngol Head Neck Surg
Uvulopalatopharyngoplasty in the sleep apnea syndrome. Predictors of results
Arch Otolaryngol Head Neck Surg
Partial upper airway obstruction in sleep after uvulopalatopharyngoplasty
Arch Otolaryngol Head Neck Surg
Cited by (73)
Analysis of CPAP failures
2019, Sleep Apnea and Snoring: Surgical and Non-Surgical TherapyEffect of continuous positive airway pressure on insulin growth factor-1 in patients with obstructive sleep apnea: A meta-analysis
2015, Growth Hormone and IGF ResearchCitation Excerpt :CPAP is the most efficient therapy for maintaining upper-airway patency during sleep. CPAP treatment improves sleep architecture and oxygen saturation [29], and these factors contribute to the low levels of IGF-1 in OSA patients. Therefore, it is not unexpected that CPAP therapy could increase IGF-1 levels in OSA patients.
Sleep apnea in patients with oral cavity and oropharyngeal cancer after surgery and chemoradiation therapy
2010, Otolaryngology - Head and Neck SurgeryCitation Excerpt :CPAP is an effective therapy for OSA, significantly reducing OSA symptoms in a vast majority of cases.17 Successful application of CPAP can dramatically improve the health-related quality of life of patients and transform somnolent individuals into energetic and more productive people.18 Unfortunately, many patients experience CPAP therapy as obtrusive, and the acceptance and long-term compliance of CPAP are typically poor.19
Analysis of NCPAP failures
2009, Sleep Apnea and SnoringBench study of auto-CPAP devices using a collapsible upper airway model with upstream resistance
2008, Respiratory Physiology and NeurobiologyAnalysis of NCPAP failures
2008, Sleep Apnea and Snoring: Surgical and Non-Surgical Therapy